Effects of Capsanthin on the Dopamine System and Dopamine-Related Social Behavior

Jae-Won Jung¹, Na-Hyun Kim¹, Yong Heo^{2, 3}, Jong-Sik Jin⁴ and Young-A Lee^1,

¹Department of Food Science and Nutrition, Daegu Catholic University, 13-13 Hayang-ro, Hayang-eup, Gyeongsan, Gyeongbuk 38430, Republic of Korea

²Department of Health and Safety, College of Bio and Medical Sciences, Daegu Catholic University, 13-13 Hayang-ro, Hayang-eup, Gyeongsan, Gyeongbuk 38430, Republic of Korea

³Graduate School Department of Toxicology, Daegu Catholic University, 13-13 Hayang-ro, Hayang-eup, Gyeongsan, Gyeongbuk 38430, Republic of Korea

⁴Department of Oriental Medicine Resources, Jeonbuk National University, 79 Gobong-ro Iksan, Jeonbuk 54596, Republic of Korea

Cite this paper:
Jae-Won Jung, Na-Hyun Kim, Yong Heo, Jong-Sik Jin and Young-A Lee. Effects of Capsanthin on the Dopamine System and Dopamine-Related Social Behavior. Journal of Food and Nutrition Research. 2024; 12(7):355-362. doi: 10.12691/jfnr-12-7-2

Abstract

Capsanthin, from paprika (Capsicum annuum), is a carotenoid with an orange-red pigment. It possesses pharmacological effects such as anti-obesity, antidiabetic, and anticancer activities. However, whether capsanthin affects the dopaminergic system remains unclear. Herein, we investigated its impact on the dopaminergic system and dopamine-associated social behaviors. Cerebral cortical neurons were cultured and treated with capsanthin (3, 30, and 300 μg/ml). Immunostaining was used to investigate dopamine-related protein expression. Healthy, wild-type ICR mice were used for animal experiments. Capsanthin (30 mg/kg) was orally administered via a gavage feeding tube from postnatal days 21 to 28. Behavioral tests, including motility, social-preference, and social-interaction tests, were conducted on juvenile mice from postnatal days 28 to 35 and on adult mice from postnatal day 56 onwards. Capsanthin treatment resulted in significantly reduced expression of dopamine receptors D3 and D5 in cerebral cortical neurons. Capsanthin administration induced a significant elevation in social preference during both the juvenile and adult periods, whereas enhancement of social interaction was observed only during the adult period. This study suggests that capsanthin enhanced social behavior via the dopaminergic system, especially through dopamine receptors D3 and D5. These findings propose capsanthin as a potential candidate for the amelioration of dopamine-associated psychiatric disorders, including schizophrenia and major depressive disorder.

Keywords:
Capsanthin dopamine dopamine receptor locomotion social preference social interaction

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Juárez Olguín, H., Calderón Guzmán, D., Hernández García, E. and Barragán Mejía, G., "The role of dopamine and its dysfunction as a consequence of oxidative stress," Oxidative medicine and cellular longevity, 2016. 9730467. Dec.2016.
[2]	Martel, J.C. and Gatti McArthur, S., "Dopamine receptor subtypes, physiology and pharmacology: New ligands and concepts in schizophrenia," Frontiers in pharmacology, 11. 1003. Jul.2020.
[3]	Mishra, A., Singh, S. and Shukla, S., "Physiological and functional basis of dopamine receptors and their role in neurogenesis: Possible implication for Parkinson’s disease," Journal of experimental neuroscience, 12. 1179069518779829. May.2018.
[4]	Salatino-Oliveira, A., Rohde, L.A. and Hutz, M.H., "The dopamine transporter role in psychiatric phenotypes," American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics, 177 (2). 211-231. Mar.2018.
[5]	Jin, Y., Gao, Q., Wang, Y., Dietz, M., Xiao, L., Cai, Y., Bliksted, V. and Zhou, Y. "Impaired social learning in patients with major depressive disorder revealed by a reinforcement learning model," International journal of clinical and health psychology: IJCHP, 23 (4). 100389. Oct.-Dec.2023.
[6]	Wang, Y., Zhou, Y., Li, S., Wang, P., Wu, G.-W. and Liu, Z.-N., "Impaired social decision making in patients with major depressive disorder," BMC psychiatry, 14. 18. Jan.2014.
[7]	Belujon, P. and Grace, A.A., "Dopamine system dysregulation in major depressive disorders," The international journal of neuropsychopharmacology, 20 (12). 1036-1046. Dec.2017.
[8]	Mandic-Maravic, V., Grujicic, R., Milutinovic, L., Munjiza-Jovanovic, A. and Pejovic- Milovancevic, M., "Dopamine in autism spectrum disorders-Focus on D2/D3 partial agonists and their possible use in treatment," Frontiers in psychiatry, 12. 787097. Feb.2021.
[9]	Matta, R., Tiessen, A.N. and Choleris, E., "The role of dorsal hippocampal dopamine D1-type receptors in social learning, social interactions, and food intake in male and female mice," Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 42 (12). 2344-2353. Nov.2017.
[10]	Dai, B., Sun, F., Tong, X., Ding, Y., Kuang, A., Osakada, T., Li, Y. and Lin, D., "Responses and functions of dopamine in nucleus accumbens core during social behaviors," Cell reports, 40 (8). 111246. Aug.2022.
[11]	Sotoyama, H., Inaba, H., Iwakura, Y., Namba, H., Takei, N., Sasaoka, T. and Nawa, H., "The dual role of dopamine in the modulation of information processing in the prefrontal cortex underlying social behavior," FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 36 (2). e22160. Feb.2022.
[12]	Waløen, K., Kleppe, R., Martinez, A. and Haavik, J., "Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease," Expert opinion on therapeutic targets, 21 (2). 167-180. Feb.2017.
[13]	Véronneau-Veilleux, F., Robaey, P., Ursino, M. and Nekka, F., "A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learning," Frontiers in computational neuroscience, 16. 849323. Jul.2022.
[14]	Wise, R.A. and Jordan, C.J., "Dopamine, behavior, and addiction," Journal of biomedical science, 28 (1). 83. Dec.2021.
[15]	Li, P., Snyder, G.L. and Vanover, K.E., "Dopamine targeting drugs for the treatment of schizophrenia: Past, present and future," Current topics in medicinal chemistry, 16 (29). 3385-3403. Dec.2016.
[16]	Lanz, J., Biniaz-Harris, N., Kuvaldina, M., Jain, S., Lewis, K. and Fallon, B.A., "Disulfiram: Mechanisms, applications, and challenges," Antibiotics (Basel, Switzerland), 12 (3). 524. Mar.2023.
[17]	Brandão-Teles, C., de Almeida, V., Cassoli, J.S. and Martins-de-Souza, D., "Biochemical pathways triggered by antipsychotics in human oligodendrocytes: Potential of discovering new treatment targets," Frontiers in pharmacology, 10. 186. Mar.2019.
[18]	Stokes, M. and Abdijadid, S., Disulfiram. StatPearls Publishing, Treasure Island (FL), 2024. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK459340/. [Accessed Jul. 5, 2024].
[19]	Zhang, Y., Yin, L., You, C., Liu, C., Dong, P., Xu, X. and Zhang, K., "Efficacy and safety of methylphenidate and atomoxetine in medication-naive children with attention-deficit hyperactivity disorder in a real-world setting," Drugs in R&D, 24 (1). 29-39. Mar.2024.
[20]	Kennedy, L.E., Abraham, A., Kulkarni, G., Shettigar, N., Dave, T. and Kulkarni, M., "Capsanthin, a plant-derived xanthophyll: A review of pharmacology and delivery strategies," AAPS PharmSciTech, 22 (5). 203. Jul.2021.
[21]	Xiang, Q., Guo, W., Tang, X., Cui, S., Zhang, F., Liu, X., Zhao, J., Zhang, H., Mao, B. and Chen, W., "Capsaicin—the spicy ingredient of chili peppers: A review of the gastrointestinal effects and mechanisms," Trends in food science & technology, 116. 755-765. Oct.2021.
[22]	Suganuma, H., Hirano, T., Kaburagi, S., Hayakawa, K. and Inakuma, T., "Ameliorative effects of dietary carotenoids on memory deficits in senescence-accelerated mice (SAMP8)," International congress series, 1260. 129-135. Feb.2004.
[23]	Davinelli, S., Ali, S., Solfrizzi, V., Scapagnini, G. and Corbi, G., "Carotenoids and cognitive outcomes: A meta-analysis of randomized intervention trials," Antioxidants (Basel, Swwitzerland), 10 (2). 223. Feb.2021.
[24]	Yuan, C., Chen, H., Wang, Y., Schneider, J.A., Willett, W.C. and Morris, M.C., "Dietary carotenoids related to risk of incident Alzheimer dementia (AD) and brain AD neuropathology: A community-based cohort of older adults," The American journal of clinical nutrition, 113 (1). 200-208. Jan.2021.
[25]	Fengjuan, J., Role of carotenoids in Parkinson’s diseases. In: Venketeshwer Rao, A. and Rao, L. (eds.) Dietary carotenoids - sources, properties, and role in human health. IntechOpen, Rijeka, 2023, 1-21.
[26]	Schneider, C.A., Rasband, W.S., and Eliceiri, K.W., "NIH Image to ImageJ: 25 years of image analysis," Nature methods, 9 (7). 671-675. Jul.2012.
[27]	Friard, O. and Gamba, M., "BORIS: A free, versatile open-source event-logging software for video/audio coding and live observations," Methods in ecology and evolution, 7 (11). 1325-1330. May.2016.
[28]	Geng, Y., Yates, C. and Peterson, R.T., "Social behavioral profiling by unsupervised deep learning reveals a stimulative effect of dopamine D3 agonists on zebrafish sociality," Cell reports methods, 3 (1). 100381. Jan.2023.
[29]	Wang, J., Jia, Y., Li, G., Wang, B., Zhou, T., Zhu, L., Chen, T. and Chen, Y., "The dopamine receptor D3 regulates lipopolysaccharide-induced depressive-like behavior in mice," The international journal of neuropsychopharmacology, 21 (5). 448-460. May.2018.
[30]	Albeely, A.M., Nolan, C.J., Rasmussen, D.J., Bailey, C.D.C. and Perreault, M.L., Cortical dopamine D5 receptors regulate neuronal circuit oscillatory activity and memory in rats. CNS neuroscience & therapeutics, 29 (9). 2469-2480. Sep.2023.
[31]	Schaack, A.K., Mocchi, M., Przybyl, K.J. and Redei, E.E., "Immediate stress alters social and object interaction and recognition memory in nearly isogenic rat strains with differing stress reactivity," Stress (Amsterdam, Netherlands), 24 (6). 911-919. Nov.2021.
[32]	Money, K.M. and Stanwood, G.D., "Developmental origins of brain disorders: Roles for dopamine," Frontiers in cellular neuroscience, 7. 260. Dec.2013.
[33]	Lee, Y.A., Kim, Y.J., Lee, J.S., Lee, S. and Goto, Y., "Imbalance between dopamine and serotonin caused by neonatal habenula lesion," Behavioural brain research, 409. 113316. Jul.2021.
[34]	Kim, Y.J., Jeon, S.Y., Choi, J.S., Kim, N.H., Goto, Y. and Lee, Y.A., "Alterations of amygdala-prefrontal cortical coupling and attention deficit/hyperactivity disorder-like behaviors induced by neonatal habenula lesion: Normalization by Ecklonia stolonifera extract and its active compound fucosterol," Behavioural pharmacology, 32 (4). 308-320. Jun.2021.
[35]	Molas, S., Freels, T.G., Zhao-Shea, R., Lee, T., Gimenez-Gomez, P., Barbini, M., Martin, G.E. and Tapper, A.R., "Dopamine control of social novelty preference is constrained by an interpeduncular-tegmentum circuit," Nature communications, 15 (1). 2891. Apr.2024.
[36]	Wang, J., Li, J., Yang, Q., Xie, Y.K., Wen, Y.L., Xu, Z.Z., Li, Y., Xu, T., Wu, Z.Y., Duan, S. and Xu, H., "Basal forebrain mediates prosocial behavior via disinhibition of midbrain dopamine neurons," Proceedings of the National Academy of Science of the United States of America, 118 (7). e2019295118. Feb.2021.
[37]	Socha, J., Grochecki, P., Smaga, I., Jastrzębska, J., Wronikowska-Denysiuk, O., Marszalek-Grabska, M., Slowik, T., Kotlinski, R., Filip, M., Lubec, G. and Kotlinska, J.H., "Social interaction in adolescent rats with neonatal ethanol exposure: Impact of sex and CE-123, a selective dopamine reuptake inhibitor," International journal of molecular sciences, 25 (2). 1041. Jan.2024.
[38]	Sato, M., Nakai, N., Fujima, S., Choe, K.Y. and Takumi, T., "Social circuits and their dysfunction in autism spectrum disorder," Molecular psychiatry, 28 (8). 3194-3206. Aug.2023.
[39]	Madeira, N. and Márquez, C., "Independent neural circuits encode the dynamics of social interaction in rats," PLoS biology, 21 (11). e3002396. Nov.2023.